Ledger.Open graph →
SEC Form D · filed October 29, 2020

Jounce Therapeutics, Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Kimberlee C. Drapkin · Cambridge, MAExecRobert G. Iannone · Cambridge, MADirectorPerry G. Karsen · Cambridge, MADirectorCary G. Pfeffer · Cambridge, MADirectorRobert G. Kamen · Cambridge, MADirectorDuncan G. Higgons · Cambridge, MADirectorRobert G. Iannone · Cambridge, MADirectorHugh M. Cole · Cambridge, MAExecRobert G. Tepper · Cambridge, MADirectorPerry G. Karsen · Cambridge, MADirectorHugh M. Cole · Cambridge, MAExecKimberlee C. Drapkin · Cambridge, MAExecBarbara G. Duncan · Cambridge, MADirectorLuis A. G. Diaz, Jr · Cambridge, MADirectorCary G. Pfeffer · Cambridge, MADirectorRichard Murray · Albuquerque, NMExec · DirectorRobert G. Tepper · Cambridge, MADirectorElizabeth G. Trehu · Cambridge, MAExecBarbara G. Duncan · Cambridge, MADirectorLuis A. G. Diaz, Jr · Cambridge, MADirectorDuncan G. Higgons · Cambridge, MADirectorRobert G. Kamen · Cambridge, MADirectorRichard Murray · Cambridge, MAExec · DirectorElizabeth G. Trehu · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗